Rupert Davies

Rupert Davies is an experienced professional in the field of translational medicine and biotechnology, currently serving as Executive Director of Translational Medicine at Alpine Immune Sciences, Inc. since May 2022. Prior to this role, Rupert held various positions at Zymeworks Inc. from January 2015 to April 2022, including Senior Director of Translational Sciences, Director of Pharmacokinetics, Principal Scientist in Oncology, and Senior Scientist in Preclinical Development. Rupert's experience also includes serving as Preclinical Manager at Amgen, Manager of Preclinical Development at Sarepta Therapeutics, and Manager of R&D at Implicit Bioscience. Rupert founded Allomodus, LLC, and has held a Senior Fellow position at the University of Washington. Rupert earned a PhD in Bioengineering from the University of Utah and a BSE in Civil and Environmental Engineering from the University of Michigan, with post-doctoral studies in Bioengineering from the University of Washington.